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ABSTRACT 
 
DRUG UTILIZATION STUDY ON PSORIASIS PATIENTS  
(Study was done at  RSUD Dr. Soetomo Surabaya) 
 
Nurul Amirah Binti Alias 
 
 Psoriasis is a skin disease included in the group of 
erythrosquamous dermatoses. The disease is chronic residive with a tightly 
defined erythema macular lesion covered by a plated asymmetal column, 
clear white as mica, accompanied by wax drip phenomenon, Auspitz sign 
and Koebner phenomenon. The purpose of this study was to analyze the 
profile of drug use in psoriasis patients including the type, dose, route of 
administration, frequency, and duration of drug administration and also to 
describe Drug Related Problems (DRPs) that may occur related to the use of 
therapy including drug side effects and drug interactions. This is an 
observational study that is retrospective. The sample was all patients with 
psoriasis who received psoriasis therapy at Inpatient Installation (IRNA) 
Medical Room Kemuning I and Kemuning II RSUD Dr. Soetomo Surabaya 
during the period of January 1, 2016 until December 31, 2017. The number 
of research samples that meet the inclusion criteria was 40 patients. 
Distribution of patients with sex-based psoriasis is 60% of men and 40% of 
women with age range between 15 years - 44 years are the most psoriasis 
sufferers. While most types of psoriasis suffered by patients is psoriasis 
vulgaris. The results showed that most use of therapy given in RSUD Dr. 
Soetomo is topical corticosteroid, immunosuppressant and skin care. 
Methotrexate as immunosuppressant was used (77%). Methotrexate is given 
orally at a dose of 2.5mg and frequency 2 times daily for 6-7 days. The 
most widely used topical corticosteroids are Desoximethasone ointment 
(55%) and he most widely used skin care is vaseline album (63%). 
Supportive therapy provided includes antihistamines (Cetirizine), antibiotics 
(doxycycline), folic acid and others. The complex of drugs used in therapy 
can lead to Drug Related Problems (DRPs), the most common of which 
33% of patients receiving Methotrexate therapy experience adverse effects 
of SGOT and SGPT increase so monitoring liver function is required. 
Psoriasis may occur due to the presence of drug-induced, therefore, it is 
necessary to monitor the potential drug inducing psoriasis such as β-
blocker, tetracycline, or oral / systemic corticosteroids (withdrawal effects 
of corticosteroid use). In addition, there is a need for good PASI 
measurements at the start of admission to the hospital and out of the 
hospital, to evaluate the decrease in the severity of psoriasis in the patient. 
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